Right to Try Clarification Act
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Jul 20, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 20, 2022
Sponsor introductory remarks on measure. (CR E757)
Jul 20, 2022
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Right to Try Clarification Act
This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cite this page
U.S. Congress. (2026). H.R. 8440: Right to Try Clarification Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8440/
"H.R. 8440: Right to Try Clarification Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8440/.
H.R. 8440, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8440/.
[H.R. 8440: Right to Try Clarification Act](https://openamerica.io/bill/117-HR-8440/)